Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
Authors:
- 1 July 2007
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (1) , 128-134
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Drug-induced liver injury: Summary of a single topic clinical research conferenceHepatology, 2006
- Herbal hepatotoxicityJournal of Hepatology, 2005
- Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and deathClinical Gastroenterology and Hepatology, 2005
- Association between NAD(P)H: Quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tractInternational Journal of Cancer, 2003
- Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosisHepatology, 2002
- Drug-induced liver diseasesJournal of Hepatology, 2000
- Plasma Carotenoids, Glutathione S-Transferase M1 andT1 Genetic Polymorphisms, and Risk of Hepatocellular Carcinoma: Independent and Interactive EffectsAmerican Journal of Epidemiology, 1999
- Genetic predisposition to drug-induced hepatotoxicityJournal of Hepatology, 1997
- Importance and Regulation of Hepatic GlutathioneSeminars in Liver Disease, 1990
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990